StockData
MacroGenics Inc logo

MacroGenics Inc (MGNX) stock

MGNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.97−0.08 (-3.90%)

Close on Nov 18, 2026Market cap $125.49MP/E –Yield –

MacroGenics net income

Net income is the profit left for shareholders after every expense, interest and tax.

MacroGenics's net income for the twelve months ending Jun 30, 2026 was -$14.59M. For fiscal 2025 it was -$74.62M. The highest annual figure on record is $8.36M in fiscal 2012.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$74.62M–
FY2024Dec 31, 2024-$66.97M–
FY2023Dec 31, 2023-$9.06M–
FY2022Dec 31, 2022-$119.76M–
FY2021Dec 31, 2021-$202.12M–
FY2020Dec 31, 2020-$129.74M–
FY2019Dec 31, 2019-$151.81M–
FY2018Dec 31, 2018-$171.45M–
FY2017Dec 31, 2017-$19.63M–
FY2016Dec 31, 2016-$58.53M–
FY2015Dec 31, 2015-$20.14M–
FY2014Dec 31, 2014-$38.31M–
FY2013Dec 31, 2013-$261.00K-103.1%
FY2012Dec 31, 2012$8.36M+24.5%
FY2011Dec 31, 2011$6.72M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$19.52M–
Q1 FY2026Mar 31, 2026-$36.77M–
Q4 FY2025Dec 31, 2025-$14.16M–
Q3 FY2025Sep 30, 2025$16.82M-70.1%
Q2 FY2025Jun 30, 2025-$36.25M–
Q1 FY2025Mar 31, 2025-$41.04M–
Q4 FY2024Dec 31, 2024-$15.42M–
Q3 FY2024Sep 30, 2024$56.31M+220.8%
Q2 FY2024Jun 30, 2024-$55.66M-196.9%
Q1 FY2024Mar 31, 2024-$52.19M–
Q4 FY2023Dec 31, 2023-$46.07M-459.9%
Q3 FY2023Sep 30, 2023$17.55M–
Q2 FY2023Jun 30, 2023$57.47M–
Q1 FY2023Mar 31, 2023-$38.01M–
Q4 FY2022Dec 31, 2022$12.80M–
Q3 FY2022Sep 30, 2022-$24.81M–
Q2 FY2022Jun 30, 2022-$41.30M–
Q1 FY2022Mar 31, 2022-$66.44M–
Q4 FY2021Dec 31, 2021-$58.02M–
Q3 FY2021Sep 30, 2021-$52.89M–
Q2 FY2021Jun 30, 2021-$39.94M–
Q1 FY2021Mar 31, 2021-$51.27M–
Q4 FY2020Dec 31, 2020-$2.09M–
Q3 FY2020Sep 30, 2020-$36.04M–
Q2 FY2020Jun 30, 2020-$46.89M–
Q1 FY2020Mar 31, 2020-$44.72M–
Q4 FY2019Dec 31, 2019-$30.40M–
Q3 FY2019Sep 30, 2019-$44.63M–
Q2 FY2019Jun 30, 2019-$31.77M–
Q1 FY2019Mar 31, 2019-$45.02M–
Q4 FY2018Dec 31, 2018-$44.64M-142.2%
Q3 FY2018Sep 30, 2018-$34.03M–
Q2 FY2018Jun 30, 2018-$43.24M–
Q1 FY2018Mar 31, 2018-$49.54M–
Q4 FY2017Dec 31, 2017$105.73M–
Q3 FY2017Sep 30, 2017-$47.04M–
Q2 FY2017Jun 30, 2017-$40.65M–
Q1 FY2017Mar 31, 2017-$37.66M–
Q4 FY2016Dec 31, 2016-$34.78M–
Q3 FY2016Sep 30, 2016-$33.85M–

More MacroGenics figures

See a number that looks wrong?